Gene · 1024
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance. | bioRxiv | 2025 | 41000885 | PubTator, text mining | PubMed |
| MiR-203a-3p in extracellular vesicles derived from mesenchymal stem cells alleviates BPD-associated apoptosis and inflammation. | Stem Cell Res Ther | 2025 | 40993819 | PubTator, text mining | PubMed |
| Overcoming resistance in RET-altered cancers through rational inhibitor design and combination therapies. | Bioorg Chem | 2025 | 40913959 | PubTator, text mining | PubMed |
| MDS-associated SF3B1 mutations promote aberrant fate choice of hematopoietic stem cell via mis-splicing of mediator kinase module component CDK8. | bioRxiv | 2025 | 40894548 | PubTator, text mining | PubMed |
| Target discovery-directed pharmacological mechanism elucidation of bioactive natural products. | Med Rev (2021) | 2025 | 40838108 | PubTator, text mining | PubMed |
| MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines. | Cell Mol Life Sci | 2025 | 40833497 | PubTator, text mining | PubMed |
| A phosphorylation switch in the Mediator MED15 controls cellular senescence and cognitive decline. | Cell Discov | 2025 | 40825935 | PubTator, text mining | PubMed |
| Discovery of lipid metabolism-related diagnostic biomarkers and construction of diagnostic model in steroid-induced osteonecrosis of femoral head. | Open Med (Wars) | 2025 | 40823179 | PubTator, text mining | PubMed |
| CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma. | bioRxiv | 2025 | 40791356 | PubTator, text mining | PubMed |
| Lysosome-derived biomarkers for predicting survival outcome in acute myeloid leukemia. | Discov Oncol | 2025 | 40751887 | PubTator, text mining | PubMed |
| New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy. | J Pharm Anal | 2025 | 40747342 | PubTator, text mining | PubMed |
| Health risks and genetic architecture of objectively measured multidimensional sleep health. | Nat Commun | 2025 | 40745165 | PubTator, text mining | PubMed |
| Selective Dual Inhibition of TNKS1 and CDK8 by TCS9725 Attenuates STAT1/β-Catenin/TGFβ1 Signaling in Renal Cancer. | Curr Issues Mol Biol | 2025 | 40699862 | PubTator, text mining | PubMed |
| Mediator Kinase Inhibitor Selectivity and Activity in Colorectal Cancer. | ACS Chem Biol | 2025 | 40601435 | PubTator, text mining | PubMed |
| A comprehensive description of cyclin-dependent kinase 8 (CDK8) inhibitors as anticancer agents. | Bioorg Med Chem | 2025 | 40555028 | PubTator, text mining | PubMed |
| MED13L pathogenic missense variants impair protein stability and interaction, underlying diverse clinical outcomes. | HGG Adv | 2025 | 40500968 | PubTator, text mining | PubMed |
| A multi-omics exploration of PPARG activation in colon cancer: kinases featuring a PPRE sequence within regulatory regions. | Biol Direct | 2025 | 40500799 | PubTator, text mining | PubMed |
| Residence time in drug discovery: current insights and future perspectives. | Pharmacol Rep | 2025 | 40489055 | PubTator, text mining | PubMed |
| Inducible protein degradation reveals inflammation-dependent function of the Treg cell lineage-defining transcription factor Foxp3. | Sci Immunol | 2025 | 40478934 | PubTator, text mining | PubMed |
| Inhibition of CDK8 rescues impaired ischemic fracture healing. | Res Sq | 2025 | 40470203 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1024/papers?page=4